Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Applied DNA Sciences Inc.

    NASDAQ: APDN · Real-Time Price · USD
    4.45
    -0.67 (-13.09%)
    At close: Jun 17, 2025, 10:40 AM

    Applied DNA Sciences Statistics

    Share Statistics

    Applied DNA Sciences has 519K shares outstanding. The number of shares has increased by 0.04% in one year.

    Shares Outstanding

    n/a
    		 519K

    Shares Change (YoY)

    n/a
    		 0.04%

    Shares Change (QoQ)

    n/a
    		 0.79%

    Owned by Institutions (%)

    n/a
    		 0.08%

    Shares Floating

    n/a
    		 512.99K

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.39M, so 266.95% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.39M

    Short % of Shares Out

    n/a
    		 266.95%

    Short % of Float

    n/a
    		 266.96%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -18.43 and the forward PE ratio is -0.06. Applied DNA Sciences's PEG ratio is 0.21.

    PE Ratio

    n/a
    		 -18.43

    Forward PE

    n/a
    		 -0.06

    PS Ratio

    n/a
    		 37.55

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 14.09

    P/FCF Ratio

    n/a
    		 -9.13

    PEG Ratio

    n/a
    		 0.21
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Applied DNA Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 3.36

    Quick Ratio

    n/a
    		 3.17

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $74,596.09

    Profits Per Employee

    n/a
    		 $-152,011.33

    Employee Count

    n/a
    		 46

    Asset Turnover

    n/a
    		 0.27

    Inventory Turnover

    n/a
    		 5.51

    Taxes

    Income Tax

    n/a
    		 137.3K

    Effective Tax Rate

    n/a
    		 -1.94%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.05, so Applied DNA Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.05

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 10.81

    200-Day Moving Average

    n/a
    		 207.97

    Relative Strength Index (RSI)

    n/a
    		 27.78

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, Applied DNA Sciences had revenue of 3.43M and earned -6.99M in profits. Earnings per share was -1.82.

    Revenue

    n/a
    		 3.43M

    Gross Profit

    n/a
    		 1.02M

    Operating Income

    n/a
    		 -14.02M

    Net Income

    n/a
    		 -6.99M

    EBITDA

    n/a
    		 -13.33M

    EBIT

    n/a
    		 -14.02M

    Earnings Per Share (EPS)

    n/a
    		 -1.82
    Full Income Statement

    Balance Sheet

    The company has 6.43M in cash and 739.16K in debt, giving a net cash position of 5.69M.

    Cash & Cash Equivalents

    n/a
    		 6.43M

    Total Debt

    n/a
    		 739.16K

    Net Cash

    n/a
    		 5.69M

    Retained Earnings

    n/a
    		 -309.67M

    Total Assets

    n/a
    		 13.04M

    Working Capital

    n/a
    		 6.54M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -13.71M and capital expenditures -407.9K, giving a free cash flow of -14.12M.

    Operating Cash Flow

    n/a
    		 -13.71M

    Capital Expenditures

    n/a
    		 -407.9K

    Free Cash Flow

    n/a
    		 -14.12M

    FCF Per Share

    n/a
    		 -3.56
    Full Cash Flow Statement

    Margins

    Gross margin is 29.63%, with operating and profit margins of -408.72% and -203.78%.

    Gross Margin

    n/a
    		 29.63%

    Operating Margin

    n/a
    		 -408.72%

    Pretax Margin

    n/a
    		 -206.57%

    Profit Margin

    n/a
    		 -203.78%

    EBITDA Margin

    n/a
    		 -388.42%

    EBIT Margin

    n/a
    		 -408.72%

    FCF Margin

    n/a
    		 -411.47%

    Dividends & Yields

    APDN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for APDN.

    Price Target

    n/a
    		 $1125

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 2, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 2, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -39.76

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist